Pharnext Sa Stock Number Of Shares Shorted

If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.

Based on the recorded statements, Pharnext SA has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The number of shares shorted for all France stocks is 100.0% higher than that of the company.

The Macroaxis Fundamental Analysis modules help investors analyze Pharnext SA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharnext using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharnext SA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

When running Pharnext's price analysis, check to measure Pharnext's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharnext is operating at the current time. Most of Pharnext's value examination focuses on studying past and present price action to predict the probability of Pharnext's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharnext's price. Additionally, you may evaluate how the addition of Pharnext to your portfolios can decrease your overall portfolio volatility.